These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24264314)

  • 1. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
    Wang Y; Li Z; Liu N; Zhang G
    Tumour Biol; 2014 Apr; 35(4):3155-65. PubMed ID: 24264314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
    Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
    Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
    Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
    Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
    Zhang Y; Wang X; Zhang W; Gong S
    Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
    Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
    Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
    Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
    DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
    Dou K; Xu Q; Han X
    Diagn Pathol; 2013 Jul; 8():112. PubMed ID: 23819639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
    Li J; Luo F; Zhang H; Li L; Xu Y
    Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
    Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
    Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
    Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
    Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
    Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
    Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
    Zong H; Cao L; Ma C; Zhao J; Ming X; Shang M; Xu H
    Tumour Biol; 2014 Aug; 35(8):8095-101. PubMed ID: 24840634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
    Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL
    Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M; Zhao F; Zou X; Jin S; Xiong S
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.
    Peng Q; Chen Z; Lu Y; Lao X; Mo C; Li R; Qin X; Li S
    Diagn Pathol; 2014 May; 9():96. PubMed ID: 24886180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
    Chen B; Cao L; Yang P; Zhou Y; Wu XT
    Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
    Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
    Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
    Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
    Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
    Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
    Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.